APA (7th ed.) Citation

JK, K., K, K., G, Q., DC, C., EG, S., J, P., . . . MJ, M. (2026). COVID-19 Rebound in Nirmatrelvir Plus Ritonavir Treatment and Control Groups: Prospective Cohort Study. Interactive journal of medical research, 15, e80263. https://doi.org/10.2196/80263

Chicago Style (17th ed.) Citation

JK, Kueper, et al. "COVID-19 Rebound in Nirmatrelvir Plus Ritonavir Treatment and Control Groups: Prospective Cohort Study." Interactive Journal of Medical Research 15 (2026): e80263. https://doi.org/10.2196/80263.

MLA (9th ed.) Citation

JK, Kueper, et al. "COVID-19 Rebound in Nirmatrelvir Plus Ritonavir Treatment and Control Groups: Prospective Cohort Study." Interactive Journal of Medical Research, vol. 15, 2026, p. e80263, https://doi.org/10.2196/80263.